Buprenorphine Neuraxpharm

Medicinal product

(Invented) name

Buprenorphine Neuraxpharm

Active substance (s)

Buprenorfinas

Strength

0,4 mg

Pharmaceutical form

poliežuvinė plėvelė

Route (s) of administration

vartoti po liežuviu

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

N07BC01, Buprenorphine

Marketing authorisation holder

Neuraxpharm Pharmaceuticals, S.L., Ispanija

Date of authorisation

2024-12-19

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

Yes

Controlled substance type

Narkotinis

Legal basis

10(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Plėvelėje yra:	1 vnt.
Buprenorfinas	0,4 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
116081	102182	1102182	paketėlis	N7×1		Receptinis	EU/1/24/1809/001	Netiekiama	-	-	No	-	-
116082	102183	1102183	paketėlis	N28×1		Receptinis	EU/1/24/1809/002	Netiekiama	-	-	No	-	-
116083	102184	1102184	paketėlis	N56×1		Receptinis	EU/1/24/1809/003	Netiekiama	-	-	No	-	-
117610	103713	1103713	paketėlis	N49×1		Receptinis	EU/1/24/1809/013	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2024-12-19	Registruotas